RAPSN and breast cancer: At present, several blood-based DNA methylation biomarkers have been proposed for early detection of BC, such as RPTOR, MGRN1, and RAPSN, with a combined AUC of 0.79 in validation cohort I, and 0.60 and 0.62 in validation cohorts II and III, respectively27.